Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
21 February 2022 |
Main ID: |
NCT01327638 |
Date of registration:
|
11/03/2011 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Safety of Etoricoxib (MK-0663) in Patients With Spondyloarthropathy (SpA)/Ankylosing Spondylitis (AS) in Sweden (EP07013.013.11.082)
|
Scientific title:
|
Safety Data on Etoricoxib From Swedish Registries of Spondyloarthropathy/Ankylosing Spondylitis Patients |
Date of first enrolment:
|
February 15, 2011 |
Target sample size:
|
21108 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT01327638 |
Study type:
|
Observational |
Study design:
|
|
Phase:
|
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Participant attended an out-patient clinic 2001-2010.
- Participant is registered with an International Classification of diseases (ICD,
Version 10)-code corresponding to SpA/AS and AS.
Exclusion Criteria:
Not applicable.
Age minimum:
16 Years
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Spondylarthropathies; Spondylitis, Ankylosing
|
Intervention(s)
|
Drug: etoricoxib
|
Drug: nsNSAIDs
|
Drug: Other COX-2 inhibitor
|
Primary Outcome(s)
|
Number of patients who used etoricoxib
[Time Frame: Up to 7 1/2 years (Q3 2005 - 2013)]
|
Number of clinical outcomes of special interest
[Time Frame: Up to 7 1/2 years (Q3 2005 - 2013)]
|
Number of patients who used nsNSAIDs
[Time Frame: Up to 7 1/2 years (Q3 2005 - 2013)]
|
Number of patients who used other COX-2 inhibitors
[Time Frame: Up to 7 1/2 years (Q3 2005 - 2013)]
|
Number of patients with Characteristics of inflammatory SPA/AS
[Time Frame: Over a 12 year period (2001-2013)]
|
Secondary ID(s)
|
0663-159
|
EP07013.013.11.082
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|